Insights

Applications for cannabis consumption area endorsements are set to open on January 2, 2025, creating regulated spaces for adults aged 21 and older to consume cannabis products purchased at licensed... Read More >

On December 12, 2024, the New York Supreme Court in Albany County granted an Article 78 petition seeking a preliminary injunction in the case of Organic Blooms, LLC, et al. v. New York State Cannabis... Read More >

The Cannabis, Hemp, and Psychedelics Practice Group at Mandelbaum Barrett PC, chaired by Joshua S. Bauchner, released their latest newsletter on October 20th, providing key updates on their ongoing... Read More >

Governor Phil Murphy’s signing of Senate Bill 3235 on September 12, 2024, represents a significant shift in the regulation of intoxicating hemp products in New Jersey. The original intention of the... Read More >

Mandelbaum Barrett PC launched a pioneering initiative as part of our Cannabis, Hemp, and Psychedelics Practice Group: cannabis banking. This move comes as a strategic response to the growing... Read More >

Law enforcement in the tri-state area, particularly New York's Office of Cannabis Management, is intensifying efforts against illicit cannabis. This has led to increased scrutiny of hemp retailers,... Read More >

On May 1, 2024, Senators Booker, Schumer, and Wyden reintroduced the Cannabis Administration and Opportunity Act (“CAOA”). Natalie C. Diaz, Esq., explains how this legislation aims to end federal... Read More >

On April 30, 2024, the Associated Press shared news of the DEA's proposal to reclassify cannabis. Natalie Diaz, Associate in the Cannabis, Hemp & Psychedelics Practice Group, cautiously welcomed the... Read More >

According to insiders, the DEA is considering a reclassification of cannabis. The proposal, yet to undergo White House review, could mark a significant shift in federal cannabis policy. If approved,... Read More >